Editorial board member Sangeeta Sule discusses her highlights from the pediatric rheumatology sessions at the 2018 ACR/ARHP Annual Meeting in Chicago, Illinois, USA (2:14).

Editorial board member Sangeeta Sule discusses her highlights from the pediatric rheumatology sessions at the 2018 ACR/ARHP Annual Meeting in Chicago, Illinois, USA (2:14).

Sangeeta Sule, from Children’s National Hospital in Washington, DC, USA, shares her experience of how the pediatric rheumatology community is adapting to the COVID-19 pandemic, including the use of telemedicine practices (9:06).

Italian researchers report a 30-fold increase in the incidence of severe Kawasaki-like disease with the emergence of COVID-19. Read the linked commentary from Sangeeta Sule .

Sangeeta Sule gives a pediatric rheumatologist’s view on a trial looking at tofacitinib for the treatment  of polyarticular juvenile idiopathic arthritis and the potential implementation of the results in the clinic (2:55).

Sangeeta Sule discusses the current recommendations for physical activity in children with juvenile idiopathic arthritis.

Sangeeta Sule discusses the current recommendations for physical activity in children with juvenile idiopathic arthritis.

–  Sangeeta Sule, USA

–  Sangeeta Sule, USA

–  Sangeeta Sule, USA

Sunday,   November 10, 17:00–17:15. Georgia World Congress Center, Atlanta, USA Presenting author:  Grant Schulert, USA What our Editorial Board said: This abstract is important because lung disease in systemic juvenile idiopathic arthritis is increasingly being recognized as an important cause of death. Being able to identify which patients may be at increased risk for this complication is important. –  Sangeeta Sule, USA

Wednesday,   November 13, 09:00–09:15. Georgia World Congress Center, Atlanta, USA Presenting author:  Antonio Nino, USA What our Editorial Board said: This trial is of interest because it shows that belimumab is effective for children with systemic lupus erythematosus. The implication is that belimumab can be used in the pediatric population just as it is for adults. –  Sangeeta Sule, USA

Monday,   November 11, 15:15–15:30. Georgia World Congress Center, Atlanta, USA Presenting author:  Nicolino Ruperto, Italy What our Editorial Board said: This trial is of interest to pediatric rheumatologists because it shows that abatacept can be used effectively with or without concomitant methotrexate. This suggests that children may not need to be treated with both methotrexate and abatacept in order to have disease control. –  Sangeeta Sule, USA

Comment on:  COVID-19 linked to outbreak of severe Kawasaki-like disease

Editorial board member Sangeeta Sule reflects on the challenges of enabling pediatric patients to make informed decisions about their own healthcare.

Editorial board member Sangeeta Sule reflects on the challenges of enabling pediatric patients to make informed decisions about their own healthcare.

Sangeeta Sule outlines the challenges of transitioning from pediatric to adult rheumatology care, highlights key resources to support families and healthcare providers, and provides tips on managing the transition process.

Editorial board member Sangeeta Sule discusses the challenges faced when managing chronic pain in children and adolescents [ read more ].